Skip to main content
Top

21-12-2016 | Osteoarthritis | Book Chapter | Article

14. Osteoarthritis of the Hip

Authors: Matthew A. Popa, MD, Victor M. Goldberg, MD, Glenn D. Wera, MD

Publisher: Springer New York

Abstract

The study of the etiology of osteoarthritis (OA) of the hip has developed into a dynamic field over the past 50 years. Epidemiological, genetic, anatomical, and biological research indicates that hip osteoarthritis appears to be a distinct entity in comparison to arthritis that affects other joints. Significant racial and ethnic differences exist in the prevalence of hip OA. Several gene single nucleotide polymorphisms (SNPs) have been discovered that are associated with an increased risk for the development of hip OA. The ethnic distribution of these SNPs also supports the differences seen in hip OA prevalence. The notion of hip OA as a “primary” disease has been challenged by the continued development of the theory of femoroacetabular impingement (FAI). This theory posits that hip OA develops secondary to subtle anatomical differences compared to “normal” hips. The identification and surgical treatment of these differences may postpone or possibly prevent hip OA development. Advances in the understanding of important signaling pathways in OA progression, such as the Wnt and TGF-β pathways, provide potential targets for new therapeutic agents.
Literature
1.
Harris WH. Etiology of osteoarthritis of the hip. Clin Orthop Relat Res. 1986;213:20–33.
2.
Kumarasinghe DD, Hopwood B, Kuliwaba JS, Atkins GJ, Fazzalari NL. An update on primary hip osteoarthritis including altered Wnt and TGF-β associated gene expression from the bony component of the disease. Rheumatology (Oxford). 2011;50(12):2166–75.CrossRef
3.
Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res. 2004; (427 Suppl):S6–15.
4.
Cooper C, Snow S, McAlindon TE, Kellingray S, Stuart B, Coggon D, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum. 2000;43(5):995–1000.CrossRefPubMed
5.
Hoaglund FT. Primary osteoarthritis of the hip: a genetic disease caused by European genetic variants. J Bone Joint Surg Am. 2013;95(5):463–8.CrossRefPubMed
6.
Reijman M, Hazes JM, Koes BW, Verhagen AP, Bierma-Zeinstra SM. Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal. Ann Rheum Dis. 2004;63(3):226–32.CrossRefPubMedPubMedCentral
7.
Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19(11):1270–85.CrossRefPubMed
8.
Yoshimura N, Campbell L, Hashimoto T, Kinoshita H, Okayasu T, Wilman C, et al. Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol. 1998;37(11):1193–7.CrossRefPubMed
9.
Nevitt MC, Xu L, Zhang Y, Lui LY, Yu W, Lane NE, et al. Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum. 2002;46(7):1773–9.CrossRefPubMed
10.
Bremner JM, Lawrence JS, Miall WE. Degenerative joint disease in a Jamaican rural population. Ann Rheum Dis. 1968;27(4):326–32.CrossRefPubMedPubMedCentral
11.
Yeşil H, Hepgüler S, Öztürk C, Çapacı K, Yeşil M. Prevalence of symptomatic knee, hand and hip osteoarthritis among individuals 40 years or older: a study conducted in İzmir city. Acta Orthop Traumatol Turc. 2013;47(4):231–5.CrossRefPubMed
12.
Andrianakos AA, Kontelis LK, Karamitsos DG, Aslanidis SI, Georgountzos AI, Kaziolas GO, et al. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol. 2006;33(12):2507–13.PubMed
13.
Salaffi F, Carotti M, Stancati A, Grassi W. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 2005;17(4):255–63.CrossRefPubMed
14.
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133(8):635–46.CrossRefPubMed
15.
Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, et al. Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates. Ann Rheum Dis. 2008;67(10):1406–11.CrossRefPubMed
16.
Quintana JM, Arostegui I, Escobar A, Azkarate J, Goenaga JI, Lafuente I. Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med. 2008;168(14):1576–84.CrossRefPubMed
17.
Nho SJ, Kymes SM, Callaghan JJ, Felson DT. The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013;21 Suppl 1:S1–6.PubMed
18.
Kang JS, Park S, Song JH, Jung YY, Cho MR, Rhyu KH. Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea. J Arthroplasty. 2009;24(8):1178–83.CrossRefPubMed
19.
Lubega N, Mkandawire NC, Sibande GC, Norrish AR, Harrison WJ. Joint replacement in Malawi: establishment of a National Joint Registry. J Bone Joint Surg Br. 2009;91(3):341–3.CrossRefPubMed
20.
Takeyama A, Naito M, Shiramizu K, Kiyama T. Prevalence of femoroacetabular impingement in Asian patients with osteoarthritis of the hip. Int Orthop. 2009;33(5):1229–32.CrossRefPubMedPubMedCentral
21.
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35.CrossRefPubMedPubMedCentral
22.
Leveille SG. Musculoskeletal aging. Curr Opin Rheumatol. 2004;16(2):114–8.CrossRefPubMed
23.
Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009;15(8 Suppl):S230–5.PubMed
24.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.PubMed
25.
Lovald ST, Ong KL, Lau EC, Schmier JK, Bozic KJ, Kurtz SM. Mortality, cost, and downstream disease of total hip arthroplasty patients in the medicare population. J Arthroplasty. 2014;29(1):242–6.CrossRefPubMed
26.
Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage. 2004;12 Suppl A:S39–44.
27.
Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ. 1996;312(7036):940–3.CrossRefPubMedPubMedCentral
28.
Hunter DJ, Snieder H, March L, Sambrook PN. Genetic contribution to cartilage volume in women: a classical twin study. Rheumatology (Oxford). 2003;42(12):1495–500.CrossRef
29.
Chitnavis J, Sinsheimer JS, Clipsham K, Loughlin J, Sykes B, Burge PD, et al. Genetic influences in end-stage osteoarthritis. Sibling risks of hip and knee replacement for idiopathic osteoarthritis. J Bone Joint Surg Br. 1997;79(4):660–4.CrossRefPubMed
30.
Meulenbelt I, Min JL, Bos S, Riyazi N, Houwing-Duistermaat JJ, van der Wijk HJ, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet. 2008;17(12):1867–75.CrossRefPubMed
31.
Chapman K, Valdes AM. Genetic factors in OA pathogenesis. Bone. 2012;51(2):258–64.CrossRefPubMed
32.
Kerkhof HJ, Lories RJ, Meulenbelt I, Jonsdottir I, Valdes AM, Arp P, et al. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 2010;62(2):499–510.PubMedPubMedCentral
33.
Waarsing JH, Kloppenburg M, Slagboom PE, Kroon HM, Houwing-Duistermaat JJ, Weinans H, et al. Osteoarthritis susceptibility genes influence the association between hip morphology and osteoarthritis. Arthritis Rheum. 2011;63(5):1349–54.CrossRefPubMed
34.
Murray RO. The aetiology of primary osteoarthritis of the hip. Br J Radiol. 1965;38(455):810–24.CrossRefPubMed
35.
Ganz R, Leunig M, Leunig-Ganz K, Harris WH. The etiology of osteoarthritis of the hip: an integrated mechanical concept. Clin Orthop Relat Res. 2008;466(2):264–72.CrossRefPubMedPubMedCentral
36.
Streit JJ, Levine A, Barrett IJ, Cooperman DR, Goldberg V. The shape of the proximal femur influences acetabular wear patterns over time. Clin Orthop Relat Res. 2013;471(2):478–85.CrossRefPubMed
37.
Clohisy JC, Carlisle JC, Beaulé PE, Kim YJ, Trousdale RT, Sierra RJ, et al. A systematic approach to the plain radiographic evaluation of the young adult hip. J Bone Joint Surg Am. 2008;90 Suppl 4:47–66.CrossRefPubMedPubMedCentral
38.
Nötzli HP, Wyss TF, Stoecklin CH, Schmid MR, Treiber K, Hodler J. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84(4):556–60.CrossRefPubMed
39.
Meyer DC, Beck M, Ellis T, Ganz R, Leunig M. Comparison of six radiographic projections to assess femoral head/neck asphericity. Clin Orthop Relat Res. 2006;445:181–5.PubMed
40.
Beaulé PE, Hynes K, Parker G, Kemp KA. Can the alpha angle assessment of cam impingement predict acetabular cartilage delamination? Clin Orthop Relat Res. 2012;470(12):3361–7.CrossRefPubMedPubMedCentral
41.
Nicholls AS, Kiran A, Pollard TC, Hart DJ, Arden CP, Spector T, et al. The association between hip morphology parameters and nineteen-year risk of end-stage osteoarthritis of the hip: a nested case-control study. Arthritis Rheum. 2011;63(11):3392–400.CrossRefPubMedPubMedCentral
42.
Pfirrmann CW, Mengiardi B, Dora C, Kalberer F, Zanetti M, Hodler J. Cam and pincer femoroacetabular impingement: characteristic MR arthrographic findings in 50 patients. Radiology. 2006;240(3):778–85.CrossRefPubMed
43.
Reynolds D, Lucas J, Klaue K. Retroversion of the acetabulum. A cause of hip pain. J Bone Joint Surg Br. 1999;81(2):281–8.CrossRefPubMed
44.
Jamali AA, Mladenov K, Meyer DC, Martinez A, Beck M, Ganz R, et al. Anteroposterior pelvic radiographs to assess acetabular retroversion: high validity of the “cross-over-sign”. J Orthop Res. 2007;25(6):758–65.CrossRefPubMed
45.
Ganz R, Parvizi J, Beck M, Leunig M, Nötzli H, Siebenrock KA. Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res. 2003;417:112–20.
46.
Solomon L. Patterns of osteoarthritis of the hip. J Bone Joint Surg Br. 1976;58(2):176–83.PubMed
47.
Harris WH, Bourne RB, Oh I. Intra-articular acetabular labrum: a possible etiological factor in certain cases of osteoarthritis of the hip. J Bone Joint Surg Am. 1979;61(4):510–4.CrossRefPubMed
48.
Solomon L. Geographical and anatomical patterns of osteoarthritis. Br J Rheumatol. 1984;23(3):177–80.CrossRefPubMed
49.
Tannast M, Goricki D, Beck M, Murphy SB, Siebenrock KA. Hip damage occurs at the zone of femoroacetabular impingement. Clin Orthop Relat Res. 2008;466(2):273–80.CrossRefPubMedPubMedCentral
50.
Hartofilakidis G, Bardakos NV, Babis GC, Georgiades G. An examination of the association between different morphotypes of femoroacetabular impingement in asymptomatic subjects and the development of osteoarthritis of the hip. J Bone Joint Surg Br. 2011;93(5):580–6.CrossRefPubMed
51.
Hoaglund FT, Steinbach LS. Primary osteoarthritis of the hip: etiology and epidemiology. J Am Acad Orthop Surg. 2001;9(5):320–7.CrossRefPubMed
52.
Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009;11(3):224.CrossRefPubMedPubMedCentral
53.
Andriacchi TP, Mündermann A, Smith RL, Alexander EJ, Dyrby CO, Koo S. A framework for the in vivo pathomechanics of osteoarthritis at the knee. Ann Biomed Eng. 2004;32(3):447–57.CrossRefPubMed
54.
Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–707.CrossRefPubMedPubMedCentral
55.
Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005;434(7033):644–8.CrossRefPubMed
56.
Blom AB, Brockbank SM, van Lent PL, van Beuningen HM, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 2009;60(2):501–12.CrossRefPubMed
57.
Chan BY, Fuller ES, Russell AK, Smith SM, Smith MM, Jackson MT, et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage. 2011;19(7):874–85.CrossRefPubMed
58.
Karvonen RL, Miller PR, Nelson DA, Granda JL, Fernández-Madrid F. Periarticular osteoporosis in osteoarthritis of the knee. J Rheumatol. 1998;25(11):2187–94.PubMed
59.
Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone. 2006;38(3):333–41.CrossRefPubMed
60.
Logar DB, Komadina R, Prezelj J, Ostanek B, Trost Z, Marc J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab. 2007;25(4):219–25.CrossRefPubMed
61.
Westacott C. Interactions between subchondral bone and cartilage in OA. Cells from osteoarthritic bone can alter cartilage metabolism. J Musculoskelet Neuronal Interact. 2002;2(6):507–9.PubMed
62.
Chun JS, Oh H, Yang S, Park M. Wnt signaling in cartilage development and degeneration. BMB Rep. 2008;41(7):485–94.CrossRefPubMed
63.
Velasco J, Zarrabeitia MT, Prieto JR, Perez-Castrillon JL, Perez-Aguilar MD, Perez-Nuñez MI, et al. Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos Int. 2010;21(1):109–18.CrossRefPubMed
64.
Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116(5):1202–9.CrossRefPubMedPubMedCentral
65.
Hopwood B, Tsykin A, Findlay DM, Fazzalari NL. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther. 2007;9(5):R100.CrossRefPubMedPubMedCentral
66.
Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat. 2003;202(Pt 3):269–77.CrossRefPubMedPubMedCentral
67.
Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthritis Cartilage. 2007;15(6):597–604.CrossRefPubMed
68.
Scanzello CR, McKeon B, Swaim BH, DiCarlo E, Asomugha EU, Kanda V, et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum. 2011;63(2):391–400.CrossRefPubMedPubMedCentral
69.
Krasnokutsky S, Belitskaya-Lévy I, Bencardino J, Samuels J, Attur M, Regatte R, et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum. 2011;63(10):2983–91.CrossRefPubMedPubMedCentral
70.
Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis. 2007;66(12):1599–603.CrossRefPubMedPubMedCentral
71.
Torres L, Dunlop DD, Peterfy C, Guermazi A, Prasad P, Hayes KW, et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage. 2006;14(10):1033–40.CrossRefPubMed
72.
Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis. 2011;70(10):1804–9.CrossRefPubMedPubMedCentral
73.
Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–57.CrossRefPubMedPubMedCentral